What is Electromed?
Electromed, Inc. is a prominent developer, manufacturer, and marketer of airway clearance therapy and related products. Headquartered in New Prague, the company's flagship offering is the SmartVest airway clearance system, which utilizes an inflatable therapy garment and a programmable air pulse generator to assist patients with compromised pulmonary function. The SmartVest SQL System offers enhanced programmability and features for improved patient care. Electromed also provides single-patient-use SmartVest and SmartVest Wrap products for intensive care unit settings. The company primarily serves patients with chronic lung conditions such as bronchiectasis, cystic fibrosis, and neuromuscular diseases, marketing its solutions directly to physicians, healthcare providers, and patients. Founded in 1992, Electromed has built a substantial presence in the respiratory care market.
How much funding has Electromed raised?
Electromed has raised a total of $6.8M across 1 funding round:
Stock Offering
$6.8M
Stock Issuance/Offering (2010): $6.8M, investors not publicly disclosed
What's next for Electromed?
The recent major strategic investment signals a pivotal phase for Electromed, likely aimed at expanding market reach, enhancing product development, or scaling manufacturing capabilities. Given the enterprise-level funding context, the company is poised for significant growth, potentially exploring new therapeutic applications or strengthening its distribution networks. This strategic financing will be crucial in navigating the competitive medical device industry and solidifying its role as a key provider of advanced airway clearance solutions.
See full Electromed company page
